✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Colinz Laboratories Ltd.

COLINZ

Market Cap
₹11 Cr.
P/E
22.95

Colinz Laboratories Ltd.

  • Colinz Laboratories
  • Decipher Labs
  • Adline Chem Lab
FAQs on Colinz Laboratories Ltd. Shareprice

Colinz Laboratories has given better returns compared to its competitors.
Colinz Laboratories has grown at ~32.56% over the last 6yrs while peers have grown at a median rate of 15.78%

Colinz Laboratories is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Colinz Laboratories is 22.95, while 3 year average PE is 28.72.
Also latest EV/EBITDA of Colinz Laboratories is 12.3 while 3yr average is 10.33.

View FAQ's On Business
Growth Table
  • Colinz Laboratories Ltd.
  • Decipher Labs
  • Adline Chem Lab
Balance Sheet
  • Colinz Laboratories Ltd.
  • Decipher Labs
  • Adline Chem Lab
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Colinz Laboratories Ltd.
  • Decipher Labs
  • Adline Chem Lab
Cash Flow
  • Colinz Laboratories Ltd.
  • Decipher Labs
  • Adline Chem Lab
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Colinz Laboratories Ltd.
  • Decipher Labs
  • Adline Chem Lab
Quarterly Results
  • Colinz Laboratories Ltd.
  • Decipher Labs
  • Adline Chem Lab
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Colinz Laboratories Ltd. Financials

Balance sheet of Colinz Laboratories is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Colinz Laboratories is increasing.
Latest net debt of Colinz Laboratories is -₹4.91 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹13.43 Crs.

Yes, profit is increasing.
The profit of Colinz Laboratories is ₹0.49 Crs for Mar 2024, ₹0.46 Crs for Mar 2023 and ₹0.34 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Colinz Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech